Jan 05, 2026
Novo Nordisk Launches $149 Wegovy Pill, Expanding Access to GLP-1 Weight-Loss Drugs
The once-daily Wegovy pill became the first oral GLP-1 approved for weight loss in the U.S., offering an alternative to injectable treatments that have driven soaring demand.
Source: Decrypt →Related News
- Feb 06, 2026
President Trump Launches TrumpRx, Promising Lower Drug Prices: Is It Legit?
- Jan 12, 2026
YouTuber Cracks Coca-Cola's 139-Year-Old Secret Formula—Here 's the Recipe
- Jan 07, 2026
Trump Administration Flips the Food Pyramid With New Dietary Guidelines
- Dec 14, 2025
Transhumanism Branded a 'Death Cult' as Thinkers Clash Over Humanity's Future
- Dec 10, 2025
Tether Pivots to Wellness Apps and Robotics in Latest Step Away from Crypto